Clinical Trial

Adenomyosis Clinical, Imaging and Histopathology

Study acronym: AM C/I/H
Enrolling by Invitation
View on ClinicalTrials.gov →
Summary
The goal of this clinical trial is to identify and compare the results of imaging studies and evaluating adenomyosis features and post hysterectomy results and their clinical relievants as well as to describe classification for adenomyosis based on one or a combination of clinical, imaging and histopathological features. Main questions it aim to answer: What's the relation between clinical symptoms ,maging and histopathological classification of adenomyosis? Research will identify relationships between clinical symptoms, imaging and histopathological classification of adenomyosis Participants will undergo transvaginal ultrasound, non contrast pelvic MRI, hysterectomy then histopathological examination for their uterus
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-11-15; most recent amendment 2026-07-06.
Trial Details
NCT Number NCT07237932
Lead Sponsor Kafrelsheikh University
Conditions Adenomyosis
Enrollment 32 participants
Start Date 2025-04-30
Primary Completion 2026-04-30 (estimated)
Study Completion 2026-06-30 (estimated)
Updated on ClinicalTrials.gov 2026-07-08